Croda Pharma

Last night on the eve of the The World Vaccine Congress eight experts 💉 explored key issues in vaccines and showcased opportunities for research and investment in the UK at the British Consulate and British Embassy Madrid UK 🇬🇧VIP Vaccines Dinner 🇬🇧. Themes covered included: 💉importance of #collaboration across the UK ecosystem 💉the link between vaccines and #AMR 💉#OneHealth, #sustainability 💉commitment of NIHR for Industry to streamline UK regulatory and approval systems for clinical trials 💉#pandemicpreparedness and the UK Health Security Agency offer to provide a world-leading environment for the development of new, innovative vaccines. 💉Research inclusion Thank you to our Department for Business and Trade moderator Dr Linda Magee OBE, expert speakers (below) and 100+ audience of VIP guests. Lucy Chappell Isabel Oliver Brendan Fish CPI Laura Ciccardi Croda Reyes Boceta GSK Prof Saul Faust OBE Elia Torroella HIPRA #WVCEU

📣 Last call! Join us for an "Ask the Expert" session with BioProcess International where our specialists will be presenting on our newest bioprocessing solution for shear stress in cell culture. 💻 Introducing Super Refined™ Poloxamer 188: Optimised for mammalian cell culture with exceptional batch-to-batch consistency. Learn about our solutions for bioprocessing and key challenges in cell culture, analytical techniques confirming product batch-to-batch consistency and more! 📅 Date: Tuesday, October 29 ⏰ Time: 08:00 am (PDT) | 11:00 am (EDT) | 03:00 pm (GMT) | 05:00 pm (CET) Click to learn more and register: https://ow.ly/Z8Ty50TUhKO

📢 Croda Pharma WEBINAR | Introducing Super Refined™ Poloxamer 188: Optimised for mammalian cell culture with exceptional batch-to-batch consistency. 💻 On October 29th, we'll be hosting the "Ask the Expert" with BioProcess International where our specialists will be covering key topics as: ☑️ Our solutions for bioprocessing and key challenges in cell culture. ☑️ Analytical techniques confirming batch-to-batch consistency of Super Refined™ Poloxamer 188. ☑️ Consistent performance in CHO and HEK cell culture. ☑️ Live Q&A and more! Register today: https://ow.ly/BnUZ50TS6cG

At Croda, we stand in solidarity with those affected by breast cancer and are committed to raising awareness about early detection, prevention, and support. Breast cancer impacts millions of lives every year, and by coming together, we can make a difference in the fight against this disease. This time four years ago looked very different for our Communications Lead, Hattie Holt. “In October 2020 at the age of 29, I was diagnosed with triple negative breast cancer during the global COVID-19 pandemic,” Hattie said. “I underwent chemotherapy, a lumpectomy and radiotherapy and finished treatment the following August. Early detection is vital, so please get to know your normal.” October is Breast Cancer Awareness Month, and, in support of Hattie and other employees who have faced a breast cancer diagnosis, we are encouraging everyone to check regularly for new or unusual changes. For Hattie, our Purpose of using smart science to improve lives™ is even more pertinent. Hattie added: “I am super proud to work for a company that uses its smart science to contribute to the research of this disease. “Many of Avanti Research’s products are used in studies as potential components of drug delivery systems to target and treat cancerous tumours, including breast cancer, which is vital for development of next generation therapeutics and improving outcomes.” #BreastCancerAwarenessMonth

Want to learn more about our newly launched solution for bioprocessing? As a product belonging to the Super Refined™ range, Super Refined™ Poloxamer 188 meets excellent purity standards, undergoes rigorous quality testing, is offered in enhanced packaging, and is also suitable for use as a parenteral excipient in biologic formulations. Speak to an expert today! https://ow.ly/usB350TPAgW #CrodaPharma #SRP188 #Poloxamer188 #Biologics #Bioprocessing #Pharma #SuperRefinedPoloxamer188

Discover how our Super Refined™ Cottonseed reduces the potential for adverse interactions between the excipient and the API, enhancing active stability and efficacy.  Application uses include: - Solvent and vehicle for injections - Emollient vehicle for other medications - Orally as a mild cathartic  - Tablet binder - Production for oral pharmaceutical powders Lean more here and request a sample today! > https://ow.ly/Qvxq50TNXhw

🧫 PRODUCT LAUNCH | Super Refined™ Poloxamer 188, optimised for mammalian cell culture in biomanufacturing. We're pleased to announce the launch of our newest bioprocessing solution, developed to overcome batch-to-batch variation challenges in mammalian cell culture, offering the highest purity standards. Read more about how we are using smart science to bring next-generation ingredients to support our customers' complex scientific needs. Click the link and speak to an expert: https://ow.ly/kY3O50TMPPT #CrodaPharma #Pharma #SuperRefinedPoloxamer188 #Poloxamer188 #Cellculture #Bioprocessing #Biologics

Join us at AAPS PharmSci 360, the “home for pharmaceutical scientists” where attendees network across the entire drug development and delivery continuum, end to end. Stop by our talk with Dr. Sreejit Menon and Dr. Garima Sinha on the “Role of key raw materials in improving yield and safety in biomanufacturing” to explore… - Improving cell health in biomanufacturing - Improving safety profile by increasing viral clearance using a sustainable alternative to Triton™ X-100 detergent - Critical quality attributes of raw materials in bioprocessing and the importance of batch-to-batch consistency Tuesday October 22 | 9:30 am Room 360, Stage #4 | Exhibition Hall Stop by booth #2525 to learn more and speak with our industry experts. Book a meeting today!> https://ow.ly/WrgL50TLNW8

Croda Pharma will be sponsoring our #CMC and #developability track! We are honoured to have James Humphrey, Research and Technology Specialist, Croda Pharma , chairing our track featuring: Prateek Gupta, PhD, SVP and Head, Technical Development & MSAT, Stelis Biopharma Alain Beck, Senior Director, Biologics CMC and Developability, Pierre Fabre Pharmaceuticals Oren Beske, Amalgamator of Business and Biology, ATUM Dan Bach Kristensen, Principal Scientist, Symphogen Xuejun (Sherry) Gu, CTO, WuXi Biologics Alejandro I., Senior Technologist, Cell Culture Development, Lonza Victor L., Senior Expert Science & Technology, Novartis Alla Zilberman, Vice President, Technical Marketing, Cygnus Technologies, LLC Barbara Hebeis, Director Bioassay, AstraZeneca Check out our full agenda for more information on their presentation topics 👉 https://lnkd.in/dQcPshGy #festivalofbiologics #biologics

People Powering Pharma features Dr. Kerri Gaumer Freidl, Head of Insights and Innovation, Small Molecule and Protein Delivery! Join Kerri as she walks us through her career journey and how she found her “home” on the commercial side of the pharmaceutical industry. From researching for customers to exploring how her findings were applied, Kerri's curiosity led her to where she is today at Croda Pharma. Stay curious! Follow Kerri and the wider team's delivery of exciting new technologies and developments!